FDC Limited (FDC) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE258B01022
Key metrics
- Market Cap
- ₹5,545 Cr
- P/E Ratio
- 18.94
- EPS
- 17.98
- Book Value
- 152.64
- P/B Ratio
- 2.19
- ROE
- 11.32%
- ROCE
- 11.47%
- Debt / Equity
- 0.01
- Net Margin
- 13.01%
- Revenue Growth
- 2.87%
- Profit Growth
- 5.49%
- Dividend Yield
- 3%
- 52W High
- ₹527.80
- 52W Low
- ₹312.95
- Market Cap Band
- mid cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About FDC Limited
FDC Limited, together with its subsidiaries, manufactures and trades in pharmaceutical products in India, the United States, and internationally. The company offers pharmaceutical formulations for various therapeutic segments, including anti-infectives, gastrointestinal, ophthalmology, vitamins, minerals, dietary supplements, cardiovascular and anti-diabetic therapies, respiratory care, gynaecology, dermatology, and analgesics in the form of tablets, capsules, oral liquids, ophthalmic drops, topical preparations, and paediatric-friendly solutions. It also provides functional food, such as flavoured ORS powders, ready-to-drink electrolyte beverages, vitamin-enriched supplements, antioxidant blends and protein-fortified drinks; and various active pharmaceutical ingredients. The company sells its products under the Zifi, Zefu, Zocon, Amodep-AT, Zathrin, Vitcofol, Ziglim, Ziglim-M,Mycoderm, Zoxan, Cotaryl, Pyrimon DF, Zipod, Electral, and Enerzal brands. It also exports its products to approximately 50 countries. FDC Limited was founded in 1936 and is based in Mumbai, India.
- Headquarters
- Mumbai, India
- Promoter Holding
- 94.85%
The full FDC Limited analysis
Create a free account to open the complete FDC deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.